RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma

RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma

Abstract Objective To explore the efficacy and safety of RALOX-HAIC (raltitrexed plus oxaliplatin) combined with lenvatinib in the treatment of elderly patients with unresectable hepatocellular carcinoma (uHCC), aiming to provide a safer and more effective therapeutic strategy for this patient popul...

Full description

Saved in:
Bibliographic Details
Main Authors: Haohao Lu, Ya Gao, Xiangwen Xia, Qing Fu, Dongqiao Xiang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Hepatic arterial infusion chemotherapy
Targeted therapy
Tyrosine kinase inhibitors
Interventional therapy
Online Access:https://doi.org/10.1186/s12885-025-14274-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14274-x

Similar Items